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Summary 
 
 Forty pork carcass sides were assigned to 
one of four treatments: pre-rigor citrate (CIT) 
or acetate (ACE) injection, post-rigor phos-
phate plus salt (PHOS) injection, and non-
injected control (CON). Loins in 20 sides 
were injected 50 min post-mortem with 4% 
solutions of CIT or ACE to approximately 
110% of projected loin weights, and 10 
PHOS-treated loins were injected at 24 h post-
mortem to 106.6% with a 4.4% PHOS plus 
2.2% salt solution. Although CIT increased 
pH (P<0.05), neither CIT nor ACE altered 
(P>0.05) glycolytic metabolite concentrations. 
The pH increase in CIT-injected muscle was 
most likely due to its buffering ability rather 
than glycolytic inhibition. Citrate improved 
tenderness without the detrimental effects on 
color or flavor found with PHOS plus salt, but 
neither CIT nor ACE altered glycolytic me-
tabolites or improved firmness, wetness, or 
fresh visual color over CON. Poor flavor at-
tributes of the ACE treatment will discourage 
its use as an ingredient for pork enhancement 
solutions. 
 
(Key Words:  Pork, Pre-rigor Injection, Cit-
rate, Acetate, Phosphate.) 
 
Introduction 
 
 Improving pork quality traits, such as ten-
derness, juiciness, and flavor, is a common 
goal in the pork industry.  Great strides have 
been made to improve handling conditions 
and to alter genetics to remove stress suscepti-
bility, but pork quality defects have been es-
timated to cost the industry an average of 
$2.13 per carcass. It is now common practice 
to ‘enhance’ pork with solutions of phosphate, 
salt, and various other ingredients. Although 
these solutions have been shown to improve 
tenderness and juiciness, they concomitantly 
induce some negative consequences in flavor 
and consumer acceptability. 
 
 Pork quality is highly dependant on the 
relationship of pH and temperature early post-
mortem. Anaerobic glycolysis is responsible 
for pH decline in post-mortem muscle. The 
lack of oxygen and absence of a circulatory 
system from exsanguination, leads to myocel-
lular accumulation of lactate and hydrogen 
ions. If glycolysis occurs at an accelerated 
rate, pH declines too rapidly and muscle pro-
teins denature due to the combination of low 
pH and high temperature.  
 
 Citrate is recognized for its glycolysis-
inhibiting properties; it inhibits the glycolytic 
enzyme, phosphofructokinase (PFK).  This 
enzyme regulates the transfer of a phosphate 
from adenosine triphosphate (ATP) to fruc-
tose-6 phosphate (F6P), producing adenosine 
diphosphate (ADP) and fructose-1,6 bisphos-
phate (F16BP). It has been identified as a key  
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regulatory enzyme of glycolysis in post-
mortem muscle.   
 
 In previous research, injecting pork loins 1 
h post-mortem with a solution of citrate, 
phosphate, and salt increased ultimate pH val-
ues and improved color, cook loss, and shear 
force, compared with phosphate and salt-
injected controls. Sodium citrate has been 
used as a glycolysis inhibitor in beef muscle to 
improve tenderness. Sodium citrate and so-
dium acetate have been used to improve ten-
derness in beef without detrimental impact on 
flavor attributes.   
 
 The objective of our study was to deter-
mine the effects of pre-rigor injection of pork 
carcasses with sodium citrate or acetate, or 
post-rigor injection of phosphate plus salt, on 
post-mortem glycolysis, pH decline, and pork 
quality attributes, including display life and 
attributes scored by a sensory panel. 
 
Procedures 
 
 Pigs and Treatments. Two replicates of 10 
pigs were fed finishing diets containing racto-
pamine for at least 14 d before harvest. Pigs 
were weighed and assigned to pairs of similar 
weights. The four sides from each pair of pigs 
were assigned to one of four treatments: pre-
rigor citrate (CIT) injection, pre-rigor acetate 
(ACE) injection, post-rigor phosphate plus salt 
injection (PHOS), and non-injected control 
(CON).  
 
 Harvest. Twenty hours before harvest, 
pigs were fasted and transported to the Kansas 
State University Meat Laboratory. Pairs of 
pigs were harvested in random order. Pigs 
were stunned with both an electric stunning 
wand and a captive bolt stunner. After stun-
ning, pigs were exsanguinated and harvested 
according to normal procedures. After the car-
casses were split and washed, each side was 
weighed. 
 Pre-rigor Injection. At approximately 50 
min post-mortem, loins in the sides assigned 
to CIT and ACE treatments were injected with 
a 4% solution of CIT or ACE in distilled wa-
ter. A hand-held injector fitted with five 10-
cm injection needles was used to inject the 
solutions. Before injection, the skin was sliced 
perpendicular to the length of the loin at ap-
proximately 3-cm intervals to allow the injec-
tion needles to penetrate the skin and into the 
longissimus muscle.  The loins were injected 
from a point beginning opposite the last lum-
bar vertebrae to a point immediately posterior 
to the scapula. The solutions were injected at 
room temperature; injection-solution tempera-
ture was recorded for each side to ensure uni-
formity. Sides were weighed again, and pump 
percentage was calculated. It was assumed 
that the loin was 20% of the total side weight, 
and that only the loin absorbed the solution. 
The estimated injection percentage of the loins 
injected pre-rigor was 10%. 
 
 To monitor temperature decline, a tem-
perature logger was placed in the longissimus 
muscle of each side. A slice was made at the 
sirloin-loin juncture, and the temperature 
probe was inserted into the muscle at least 
2.75 inches, at a 45-degree angle to the skin 
surface. After injection, a muscle sample was 
removed from the anterior portion of the in-
jected longissimus from both sides of the car-
casses. The muscle samples were cubed, 
quick-frozen in liquid nitrogen, packaged, 
temporarily stored on dry ice, and stored at  
–80oC for pre-rigor pH and glycolytic metabo-
lite analysis. Additional muscle samples were 
removed from the longissimus muscle of each 
side at 3, 6, 12, and 24 h post-mortem and fro-
zen in liquid nitrogen as previously described.  
At least 1.5 inch of muscle was maintained 
between muscle sample locations, to minimize 
the effects of chilling rate on the cut surfaces. 
 
 Pre-rigor pH Analysis. Frozen muscle 
samples were pulverized into a powder and 
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stored at -80oC until analysis for pre-rigor pH 
and glycolytic metabolites. Duplicate 5-g 
samples of powdered muscle were mixed with 
50 ml of a solution of iodoacetate in 150 mM 
potassium chloride.  The mixture was covered 
with Parafilm and allowed to acclimate to 
room temperature for no less than 4 h.  After 
acclimation, the solution was remixed, and 
each duplicate was read twice by using two 
pH probes with a portable meter. 
 
 Glycolytic Metabolites.  Samples from 50 
min, 3 h, and 12 h were analyzed for glucose-
6 phosphate (G6P), fructose-6 phosphate 
(F6P), fructose-1,6 bisphosphate (F16BP), a 
combination of glyceraldehyde-3 phosphate 
and dihydroxyacetone phosphate (GAPDAP), 
and lactate. 
 
 Fabrication and Post-rigor Injection. At 
24 h post-mortem, loins were removed from 
the sides; the anterior section, where the mus-
cle samples were removed, was discarded. 
Loins assigned to CIT, ACE, and CON treat-
ments were vacuum packaged and stored at 
1oC.  Loins assigned to post-rigor PHOS 
treatment were injected with a solution con-
taining 4.4% sodium tripolyphosphate and 
2.2% sodium chloride by using the hand-stitch 
injector used for the CIT and ACE treatments.  
After two rounds of PHOS injection, the loins 
had absorbed 6.6% of their pre-injected 
weight.  After injection, the loins assigned to 
PHOS were vacuum packaged and stored 
overnight at 1oC. The loins were re-weighed 
after vacuum storage and found to retain 
104.6% of their pre-injected weight.  
 
 Chop Removal, Initial Pork Color, Firm-
ness, and Wetness. At 2 d post-mortem, loin 
sections were de-boned, and three 2.54-cm 
chops were removed from the posterior sec-
tion of the longissimus. One chop, for sensory-
panel analysis, was vacuum packaged and 
stored at 1oC for 8 d before freezing at –20oC. 
An additional chop was vacuum packaged and 
stored at 1oC overnight for pH and expressible 
moisture-analysis. The third chop was allowed 
to bloom for no less than 30 min and was 
evaluated by a three-member, trained visual 
panel for color, firmness, and wetness. Color 
was evaluated according to the official NPPC 
color standard cards (1 = lightest and 6 = 
darkest). Firmness and wetness were evalu-
ated separately by using three-point scales (1 
= softest or wettest and 3 = firmest or driest).  
 
 Display Color. Chops for visual evaluation 
were packaged in white foam trays with ab-
sorbent pads, over-wrapped with PVC film, 
and placed in an open-top display case under 
continuous fluorescent lighting. A trained vis-
ual panel of no fewer than six persons evalu-
ated color each day over 7 d of display. Panel-
ists scored each chop for color on a six-point 
scale (1 = extremely bright pink, 2 = bright 
pink, 3 = dull pink, 4 = slightly dark pink or 
tan, 4.5 = borderline panelist unacceptable, 5 
= moderately dark pink or tan, 6 = dark pink 
or tan) and scored for discoloration on a 
seven-point scale (1 = no discoloration (0%), 
2 = slight discoloration (1 to 19%), 3 = small 
discoloration (20 to 39%), 4 = modest discol-
oration (40 to 59%), 5 = moderate discolora-
tion (60 to 79%), 6 = extensive discoloration 
(80 to 99%), 7 = total discoloration (100%)). 
The scores for each d were averaged for 
analysis.  
 
 Display Loss. After display, packages 
were weighed.  Chops were removed, dabbed 
with a paper towel, allowed to dry for 5 min, 
and weighed again to calculate display loss, 
calculated as follows: [(pre-display weight – 
post-display weight)/pre-display weight] × 
100. 
 
 Instrumental Color. Each day of display, a 
HunterLab Miniscan XE Plus spectropho-
tometer was used to obtain L*, a*, and b* val-
ues on the over-wrapped chops. Each chop 
was measured twice with a 3.2-cm aperture, a 
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10o observer, and illuminant D65. Readings 
were averaged for analysis. 
 
 Expressible Moisture. At 3 d post-mortem, 
chops assigned to expressible-moisture 
evaluation were removed from their vacuum 
bags. A scapel and tweezers were used to re-
move duplicate samples (2 to 3 g) parallel to 
the muscle fiber direction, from the interior of 
the chop. The rest of the chop was vacuum 
packaged and stored at 1oC until pH analysis.  
Samples were weighed and placed in a 50-ml 
centrifuge tube fitted with one piece of 
Whatman No. 3 filter paper folded around one 
piece of Whatman No. 50 filter paper. The 
tubes were capped and centrifuged at 2100 
rpm for 10 min. After centrifugation, samples 
were weighed again, and expressible moisture 
was calculated.  
 
 Ultimate pH Analysis. Duplicate samples 
(10 g each) were minced with a scalpel. Sam-
ples were placed in a filtered stomacher bag 
with 100 ml of distilled water and stomached 
for 2 min. After stomaching, pH was  
measured. 
 
 Evaluations by Trained Sensory Panel.  
Chops for analysis by a trained sensory panel 
were stored frozen for 3 months and thawed 
overnight at 4oC. Chops were cooked to 70oC, 
and temperature was monitored. After cook-
ing, the outer connective tissue was removed, 
and the chops were cut into cubes and held in 
pre-heated double broilers. No fewer than six 
trained panelists were seated in an environ-
mentally controlled room. Two cubes from 
each chop were served to panelists in a statis-
tically randomized order, and a score was de-
termined by using an 8-point scale to the near-
est 0.5. Scores were determined for myofibril-
lar tenderness (1 = extremely tough, 8 = ex-
tremely tender), juiciness (1 = extremely dry, 
8 = extremely juicy), pork flavor intensity (1 = 
extremely intense pork flavor, 8 = extremely 
bland), connective tissue amount (1 = abun-
dant, 8 = none), overall tenderness (1 = ex-
tremely tough, 8 = extremely tender), and off-
flavor intensity (1 = abundant, 8 = none).   
 
 Statistical Analysis. Muscle temperature 
data were analyzed as an incomplete block 
with repeated measures, with individual pig as 
the block.  Pre-rigor pH and glycolytic me-
tabolite data were analyzed in a split-plot de-
sign, with injection treatment as the whole 
plot and time post-mortem as the subplot. Pig 
was used as the block in the whole plot. Vis-
ual color, firmness, wetness, expressible mois-
ture, and ultimate pH were analyzed in an in-
complete block, with pig as the block. Visual- 
and instrumental-display data were analyzed 
in an incomplete-block design, with the re-
peated measure of time and pig as the block. 
Data from the sensory panel were analyzed in 
an incomplete-block design, blocking on pig 
and panelist.  Injection treatment and time 
post-mortem were treated as fixed effects; pig 
and panelist were treated as random effects. 
Data were analyzed by using PROC MIXED 
in the Statistical Analysis System; means were 
separated by using the PDIFF test when 
P<0.05. For repeated-measures analysis, the 
Repeated Measures command was used with 
the autoregressive option.  
 
Results and Discussion 
 
 Temperature. At 1 h post-mortem, longis-
simus muscles from carcasses not injected 
were warmer (P<0.05) than those from CIT- 
and ACE-injected carcasses, and those from 
ACE-injected carcasses were warmer 
(P<0.05) than those from CIT-injected car-
casses (Figure 1).  Nevertheless, muscle tem-
peratures among treatments were similar 
(P>0.05) for measurements taken in 1-h in-
crements afterwards. It is probable that the 
temperature of the injection solution lowered 
the temperature of the muscle in the first few 
minutes after injection, but did not affect chill 
rate after 1 h.   
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 Pre-rigor pH. There was no time × treat-
ment interaction (P>0.05) for pre-rigor pH 
(Table 1). Longissimus muscles from CIT-
injected carcasses had the highest (P<0.05) 
pre-rigor pH values, whereas those from ACE-
injected carcasses did not differ (P>0.05) from 
CON and PHOS-injected carcasses.  The pH 
was highest (P<0.05) at 50 min post-mortem, 
and values at 3, 6, 12, and 24 h were similar 
(P>0.05), indicating that the majority of pH 
decline occurred before 3 h.  
 
 Glycolytic Metabolites.  A time × injection 
treatment interaction (P<0.05) was found for 
G6P concentration (Figure 2).  All four treat-
ments resulted in similar (P>0.05) G6P con-
centrations at 50 min post-mortem. Values for 
G6P in CON muscles increased (P<0.05) with 
post-mortem time, and were higher (P<0.05) 
than for CIT- and ACE-injected muscles at 3 
and 12 h post-mortem. In muscles designated 
for post-rigor PHOS injection, 12-h concentra-
tions of G6P were higher (P<0.05) than those 
at 50 min, and 3-h concentrations were inter-
mediate. Concentrations of G6P from longis-
simus muscles designated for PHOS injection 
were higher (P<0.05) than those from CIT-
injected muscles at 3 h, but were similar to 
those from CIT- and ACE-injected muscles at 
12 h. Concentrations of G6P from ACE- and 
CIT-injected longissimus muscles were simi-
lar (P>0.05) at 50 min and 3 h.  The 12-h G6P 
concentrations were higher than 50-min and 3-
h concentrations in ACE-injected muscles, but 
only higher than the 3-h samples in CIT-
injected carcasses.  No interaction existed for 
F6P values (P>0.05; Figure 3). The CON and 
PHOS-injected muscles had higher concentra-
tions (P<0.05) of F6P than those from ACE- 
and CIT-injected muscles did.  Concentrations 
of F6P were similar (P>0.05) at 50 min and 3 
h, but were higher (P<0.05) at 12 h.  
 
 Glucose-6 phosphate is the precursor to 
F6P, which is a substrate for PFK. Successful 
inhibition of PFK by CIT and ACE treatments 
should have resulted in elevated concentra-
tions of G6P and F6P.  Nevertheless, G6P and 
F6P concentrations were highest (P<0.05) for 
CON and PHOS-injected treatments, indicat-
ing that CIT and ACE injection activated PFK 
activity, rather than inhibited it.  Citrate in-
creases the enzyme’s affinity for ATP at the 
substrate site and activates the reaction.  Reac-
tions of rigor take place due to a drop in ATP 
concentration; pre-rigor CIT injection, in 
combination with low ATP concentrations as-
sociated with rigor, may have actually acti-
vated PFK.  Although previous researchers 
have not observed this phenomenon in post-
mortem beef muscle, pork is inherently more 
glycolytic than beef and goes into the rigor 
state at an earlier time post-mortem.  It is pos-
sible that the approximately 10% addition of 
water diluted G6P and F6P concentrations in 
the ACE- and CIT-injected longissimus mus-
cles, but this dilution effect was not evidenced 
in other metabolites.  
 
 A time × treatment interaction (P<0.05) 
was found for F16BP values (Figure 4). At 50 
min post-mortem, concentrations of F16BP in 
samples from CIT-injected muscles were 
lower (P<0.05) than those from CON. Con-
centrations of F16BP from CIT-injected mus-
cles were higher than those from ACE-
injected muscles at 3 h, and those from CON 
and PHOS were intermediate.  Levels were 
similar for all treatments at 3 and 12 h. For 
CON, PHOS-injected, and ACE-injected mus-
cles, the 50-min concentrations were higher 
(P<0.05) than at 3 and 12 h. For CIT-injected 
muscles, 50-min and 3-h F16BP concentra-
tions were similar (P>0.05) and greater than 
12-h (P<0.05) concentrations, but concentra-
tions were similar to those from CON and 
PHOS-injected muscles at 3 and 12 h.  There 
was a time × treatment interaction (P<0.05) 
for GAPDAP concentrations (Figure 5).  
Longissimus muscles designated for PHOS 
injection had larger (P<0.05) GAPDAP values 
than those from ACE-injected muscles did at 
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50 min; all other treatments were similar.  All 
treatments were similar at 3 and 12 h post-
mortem. The 50-min concentrations were 
highest (P<0.05), and the 3- and 12-h concen-
trations were similar (P>0.05) for all  
treatments.   
 
 The product of PFK is F16BP; inhibition 
of PFK should have resulted in decreased con-
centrations of F16BP for CIT- and ACE-
injected muscles. Maintenance of high con-
centrations of F16BP at 3 h for CIT-injected 
muscles could indicate that F16BP was being 
replenished by PFK as it was used, and that 
the PFK was activated rather than inhibited. 
The F16BP concentrations from CON, PHOS-
injected, and ACE-injected muscles were not 
being replenished.  Aldolase, the enzyme that 
cleaves F16BP to form GAP and DAP, oper-
ates continuously in the presence of substrate, 
F16BP.  Therefore, GAPDAP concentrations 
indicate PFK activity. Our data indicate that 
GAPDAP concentrations were not being re-
plenished by PFK for any treatment.  
 
 There was no interaction (P>0.05) for lac-
tate concentrations (Figure 6).  Muscles that 
were injected with CIT had lower (P<0.05) 
lactate concentrations than those designated 
for 24-h PHOS injection did, but CON and 
ACE-injected muscles were not different (P > 
0.05) in lactate concentration than those from 
CIT- and PHOS-injected muscles. Lactate 
concentrations increased (P<0.05) as post-
mortem time increased; and this was expected 
because lactate accumulates with time. 
 
 Glycolytic metabolite data indicate that 
CIT and ACE were ineffective as glycolytic 
inhibitors when injected into pork muscle, 
even though CIT-injected muscles had higher 
pre-rigor pH.  The CIT solution likely in-
creased muscle pH due to its buffering capac-
ity and multiple negative charges on the citrate 
ion.  Others have found that pre-rigor injection 
of beef muscles with CIT inhibited glycolysis, 
as evidenced by increased muscle pH and gly-
cogen levels.  Glycogen levels were not meas-
ured in our study. In other research, PFK was 
thought to be inactivated within 20 min post-
mortem and not affect pork quality attributes. 
Nevertheless, others have stated that PFK is 
the main rate-limiting enzyme in post-mortem 
muscle glycolysis.  Our research indicated that 
PFK was still active in the muscle after 50 min 
post-mortem when the CIT and ACE solutions 
were introduced into the muscle system, be-
cause the glycolytic metabolites were still 
changing after 50 min post-mortem.  Concen-
trations of ATP may have been at a non-
saturated state at an earlier time post-mortem, 
and PFK may have been activated by CIT in-
jection, as discussed earlier. In past research, 
CIT has been found to be inhibitory in pork, 
but that injection solution included phosphate 
and salt, which would have drastically af-
fected muscle pH. Enzyme activities are al-
tered at higher pH. Furthermore, the increase 
in ionic strength due to the phosphate and salt 
may have affected the PFK activity. 
 
 Pork Quality Attributes.  Mean values for 
visual color, firmness, and wetness, as well as 
expressible moisture, ultimate pH, and display 
loss, are presented in Table 2.  According to 
visual panelists, chops from ACE- and CIT-
injected carcasses were less firm (P<0.05) and 
wetter (P<0.05) than those from CON and 
PHOS-injected carcasses.  These inferiorities 
were not surprising because the CIT- and 
ACE-injection treatments added approxi-
mately 10% water to the longissimus muscle.  
Chops from PHOS-injected carcasses also had 
added water, but the percentage was lower 
than for CIT- and ACE-injected carcasses, and 
PHOS injection greatly increased (P<0.05) 
muscle pH. Chops from PHOS-injected car-
casses had the highest (P<0.05) ultimate pH 
values, and chops from CIT-injected carcasses 
had higher (P<0.05) ultimate pH values than 
those from CON or ACE-injected carcasses. 
Chops from CIT- and ACE-injected carcasses 
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had greater (P<0.05) display losses than those 
from PHOS and CON treatments had. Chops 
from PHOS-injected carcasses had the least 
(P<0.05) display loss. Visual color and ex-
pressible moisture were not affected by injec-
tion treatment.  
 
 Display Evaluations. Visual color scores 
increased (P<0.05) throughout display for all 
four treatments, indicating a deterioration of 
color during display (Figure 7).  Chops from 
PHOS-injected carcasses had the highest 
(darkest; P<0.05) visual scores each day of 
display, compared with those of other treat-
ments.  Chops from PHOS-injected carcasses 
were considered unacceptable (color scores 
greater than 4.5) by the panelists after 5 d of 
display; no other treatment reached that mark. 
Chops from ACE- and CIT-injected carcasses 
were similar (P>0.05) to those from CON car-
casses each day of display. Although discol-
oration scores for chops from PHOS-injected 
carcasses were similar (P>0.05) to those from 
CON carcasses for the first 2 d of display, 
they were higher (P<0.05) than scores from 
other treatments throughout the rest of the dis-
play period (Figure 8).  Chops from ACE-
injected carcasses were similar (P>0.05) to 
those from CON carcasses in discoloration 
scores throughout display.  For the first 6 d of 
display, chops from CIT-injected carcasses 
were similar (P>0.05) to those from CON car-
casses, but on the final day of display, the dis-
coloration scores were higher (P<0.05) for 
chops from CIT-injected carcasses than for 
chops from CON carcasses. 
 
 Chops from PHOS-injected loins were 
darkest (smallest L* values; P<0.05) through-
out display.  Although chops from ACE-
injected carcasses were similar (P>0.05) to 
those from CON carcasses for the first 2 d of 
display, they were lighter (P<0.05) than those 
from CON for the last 5 d of display (Figure 
9).  Chops from CIT-injected carcasses were 
similar (P>0.05) to those from CON carcasses 
in L* value throughout the display period.  
Chops from CIT-injected carcasses did not 
change (P>0.05) throughout display, whereas 
L* values for chops from PHOS-injected and 
CON carcasses peaked (P<0.05) after 1 d of 
display.  
 
 Chops from PHOS-injected carcasses were 
less red (smaller a* value; P<0.05) than those 
from CON and ACE-injected carcasses each 
day of display (Figure 10).  Chops from CIT-
injected carcasses were similar (P>0.05) to 
those from PHOS-injected carcasses on d 0 
and the final 2 d of display.  Chops from CON 
carcasses were similar to those from ACE-
injected carcasses on the first 2 d of display, 
and similar to chops from CIT-injected car-
casses after 1 d, but they had the largest a* 
values (P<0.05) the final 5 d of display. Chops 
from ACE-injected carcasses were redder 
(P<0.05) than those from CIT-injected car-
casses on d 0 and 2, but they were similar 
(P>0.05) throughout the rest of display.  Pre-
vious research found that pork chops from 
CIT-injected loins had larger a* values than 
phosphate-injected controls did, but that CIT 
treatment also included phosphate.  
 
 Chops from PHOS-injected carcasses had 
the smallest b* values (least yellow; P<0.05) 
throughout display (Figure 11); chops from 
CIT- and ACE-injected carcasses were similar 
(P>0.05) to those from CON carcasses 
throughout display. Chops from PHOS-
injected carcasses had the smallest b* values 
on d 0, but values for b* did not notably 
change (P>0.05) over time for any of the other 
treatments. Previous research in beef found 
that CIT-injected samples were less yellow 
than controls, whereas ACE-injected samples 
were similar to controls. 
 
 Sensory Attributes. Values for attributes 
evaluated by the trained sensory panel are dis-
played in Table 3. Control chops were tough-
est (P<0.05), chops from PHOS-injected car-
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casses were most tender (P<0.05), and the 
treatments injected pre-rigor were intermedi-
ate in both myofibrillar and overall tenderness.  
Control chops also had the lowest (P<0.05) 
connective tissue scores, indicating a higher 
percentage of detectable connective tissue.  
The increase in tenderness of chops from 
PHOS-injected carcasses may have been 
partly due to the swelling of myofibrils caused 
by phosphate and salt and to the dilution of the 
proteins by the injection solutions.  In other 
research, chops from CIT-injected loins had 
lower shear force values than CON.   
 
 Chops from PHOS-injected carcasses were 
also juiciest (P<0.05), whereas chops from 
CIT- and ACE-injected carcasses were similar 
(P>0.05) to those from CON carcasses.  The 
increase in ultimate pH, resulting in improved 
water holding capacity, by the PHOS injection 
likely was responsible for the improved juici-
ness of that treatment.   
 
 Chops from CON and CIT-injected car-
casses had higher (P<0.05) pork flavor inten-
sity scores and less incidence (P<0.05) of off-
flavors than those from PHOS- and ACE-
injected carcasses.  It is likely that the off-
flavors associated with the PHOS- and ACE-
injected treatments masked the pork flavor of 
the chops. The most common off-flavor de-
scriptor for chops from PHOS-injected car-
casses was salty. Other off-flavor descriptors 
of soapy, metallic, rancid, and acidic, were 
also used to describe the chops from PHOS-
injected carcasses. Chops from ACE-injected 
carcasses were most commonly described as 
sweet or sugary, as well as acidic, lemony, or 
vinegary. Other, infrequent off-flavor descrip-
tors for chops from ACE-injected carcasses 
included chemical, soapy, salty, metallic, 
cleaner fluid, and Tabasco. Although chops 
from CIT-injected and CON carcasses had 
less incidence (P<0.05) of off-flavors than 
ACE- and PHOS-injected carcasses had, some 
descriptors were provided.  Chops from CIT-
injected carcasses were infrequently described 
as acidic, metallic, salty, bitter, and rancid, 
whereas those from CON carcasses were de-
scribed as acidic, bitter, salty, and metallic.  
 
 Glycolytic-metabolite data indicated that 
the increase in pH in CIT-injected muscle was 
not due to an inhibition of glycolysis post-
mortem. The pH increase in the muscle was 
likely due to the relatively high pH of the cit-
rate solution. The very glycolytic conditions 
of pork muscle and low ATP levels during 
rigor may have overwhelmed citrate’s ability 
to inhibit glycolysis. The data reinforced the 
evidence for rate-limiting effects of PFK in 
post-mortem muscle. 
 
 Although pre-rigor CIT injection increased 
pH and improved tenderness, compared with 
CON, visual firmness and wetness were de-
creased with CIT injection. Chops from CIT-
injected carcasses were similar to those from 
CON carcasses in pork-flavor intensity, and 
there were no excessive off-flavors. Perhaps 
using CIT in conjunction with a phosphate and 
salt solution would allow for improved muscle 
water-holding capacity, and the water-soluble 
CIT in the injection-solution would be more 
accessible to PFK. 
 
 Chops from ACE-injected carcasses were 
superior to those from CON carcasses in ten-
derness, but glycolytic-metabolite and pH data 
indicated that ACE did not inhibit post-
mortem glycolysis.  Furthermore, the de-
creased pork-flavor intensity and objection-
able off-flavors of ACE injection likely will 
discourage use of this compound at this con-
centration in injection solutions for fresh meat. 
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Table 1. Mean Values for Pre-rigor pH of Longissimus Muscle From Carcasses Injected 50 
min Post-mortem with Sodium Citrate or Sodium Acetate, Non-Injected Control Car-
casses, and Carcasses Designated for 24 h Injection with Phosphate + Salt 
 Pre-rigor Injection Non-injected Injected at 24 h  
Time Acetate Citrate Control Phosphate + Salt Meanc 
50 min 5.87 5.96 6.00 5.90 5.93a 
3 h 5.45 5.58 5.49 5.49 5.51b 
6 h 5.52 5.56 5.49 5.47 5.51b 
12 h 5.49 5.52 5.46 5.44 5.48b 
24 h 5.50 5.55 5.47 5.48 5.50b 
Mean 5.57b 5.63a 5.58b 5.56b  
abMeans for times and treatments lacking common superscript letters differ (P<0.05). 
cStandard error for all means = 0.02. 
 
Table 2. Visual Evaluations, Expressible Moisture, Ultimate pH, and Display Loss Meas-
urements of Longissimus Chops from Pork Carcasses Injected 50 min Post Mortem with 
Sodium Acetate or Sodium Citrate, Non-injected Controls, or 24 h Injection with Phos-
phate + Salt 
 Pre-rigor Injection Non-injected Injected at 24 h  
Item Acetate Citrate Control Phosphate + Salt S.E.c 
Colora 3.26 3.16 4.48 4.33 0.53 
Firmnessb 1.95y 2.14y 2.36z 2.49z 0.15 
Wetnessb 1.93y 1.96y 2.46z 2.41z 0.18 
Expressible moisture 18.87 20.01 20.14 18.56 1.35 
Ultimate pH 5.51x 5.63y 5.48x 5.99z 0.03 
Display loss 9.36z 9.71z 7.45y 4.73x 0.58 
aColor was evaluated on a 6-point scale according to official color standards from the National 
Pork Producers Council (1 = lightest and 6 = darkest). 
bFirmness and wetness were evaluated separately on 3-point scales (1 = softest and wettest and 3 
= firmest and driest). 
cStandard error. 
xyzMeans, within a row, lacking common superscript letters differ (P<0.05). 
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Table 3. Mean Values and Standard Errors for Trained Sensory Panel Traits for Longis-
simus Chops from Carcasses Injected with Sodium Citrate or Sodium Acetate 50 min Post-
mortem, Non-injected Controls, and Injection with Phosphate + Salt at 24 h 
 Pre-rigor Injection Non-injected Injected at 24 h  
Item Acetate Citrate Control Phosphate + Salt S.E.f 
Myofibrillar tendernessa 5.78y 5.83y 4.81z 6.34x 0.19 
Juicinessb 5.12z 4.99z 4.83z 6.17y 0.15 
Pork flavor intensityc 4.56z 5.22y 5.19y 4.83z 0.22 
Off flavord 5.42z 7.52y 7.09y 5.30z 0.24 
Connective tissuee 7.34y 7.38y 6.94z 7.42y 0.14 
Overall tenderness 6.02y 6.13y 5.10z 6.61x 0.18 
aMyofibrillar tenderness and overall tenderness were evaluated on an 8-point scale (1 = ex-
tremely tough and 8 = extremely tender). 
 bJuiciness was evaluated on an 8-point scale (1 = extremely dry and 8 = extremely juicy). 
cPork flavor intensity was evaluated on an 8-point scale (1 = extremely bland and 8 = extremely 
intense pork flavor). 
dOff flavor was evaluated on an 8-point scale (1 = abundant and 8 = none). 
eConnective tissue amount was evaluated on an 8-point scale (1 = abundant and 8 = none). 
fStandard error. 
xyzMeans, within a row, lacking common superscript letters differ (P<0.05). 
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abc Data points, for the first temperature reading, lacking common 
superscript letters differ (P<0.05). 
 
Figure 1. Mean Longissimus muscle Temperatures of Carcasses Injected at 50 min Post-
mortem with Acetate or Citrate, Non-injected Controls, and Carcasses Designated for In-
jection with Phosphate + Salt at 24 h. 
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abcdefMeans lacking common superscript letters differ (P<0.05). 
gLargest interaction mean standard error. 
Figure 2. Mean Concentrations of Glucose-6 Phosphate in Longissimus Muscle at 50 min 
and 3 and 12 h Post-mortem from Carcasses Injected at 50 min Post-mortem with Acetate 
or Citrate, Non-injected Controls, and Carcasses Designated for Injection with Phosphate 
+ Salt at 24 h. 
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abMain effect means lacking common superscript letters (in parenthesis) differ (P<0.05), 
Standard error for ante mortem treatment main effects = 0.06, 
Standard error for time main effects = 0.05 
 
Figure 3.  Mean Concentrations of Fructose-6 Phosphate in Longissimus Muscle at 50 min 
and 3 and 12 h Post-mortem from Carcasses Injected at 50 min Postmortem with Acetate 
or Citrate, Non-injected Controls, and Carcasses Designated for Injection with Phosphate 
+ Salt at 24 h. 
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abcdeMeans lacking common superscript letters differ (P < 0.05). 
fLargest standard error for interaction means. 
 
Figure 4. Mean Concentrations of Fructose-1,6 Bisphosphate in Longissimus Muscle at 50 
min and 3 and 12 h Post-mortem from Carcasses Injected at 50 min Post-mortem with Ace-
tate or Citrate, Non-injected Controls, and Carcasses Designated for Injection with Phos-
phate + Salt at 24 h. 
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abcdeMeans lacking common superscript letters differ (P < 0.05). 
fLargest standard error for interaction means. 
 
Figure 5.  Mean Concentrations for a Combination of Glyceraldehyde-3 Phosphate and Di-
hydroxyacetone Phosphate in Longissimus Muscle at 50 min and 3 and 12 h Post-mortem 
from Carcasses Injected at 50 min Post-mortem with Acetate or Citrate, Non-injected Con-
trols, and Carcasses Designated for Injection with Phosphate + Salt at 24 h. 
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abcMain effect means lacking common superscript letters (in parenthesis) differ (P<0.05), 
Standard error for ante-mortem treatment main effect = 0.30, 
Standard error for time main effect = 0.26. 
 
Figure 6.  Mean Concentrations of Lactate in Longissimus Muscle at 50 min and 3 and 12 h 
Post-mortem from Carcasses Injected at 50 min Post-mortem with Acetate or Citrate, Non-
injected Controls, and Carcasses Designated for Injection with Phosphate + Salt at 24 h. 
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a-qMeans lacking common superscript letters differ (P<0.05). 
rStandard error of the interaction means. 
 
Figure 7. Visual Color Scores for Longissimus Chops from Acetate or Citrate Injection at 
50 min Post-mortem, Phosphate plus Salt Injection at 24 h, and Non-injected Controls over 
7 d of Display. 
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a-nMeans lacking a common superscript letter differ (P<0.05). 
oStandard error of the interaction means. 
 
Figure 8.  Discoloration Scores for Longissimus Chops from Acetate or Citrate Injection at 
50 min Post-mortem, Phosphate plus Salt Injection at 24 h, and Non-injected Controls over 
7 d of Display. 
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a-iMeans lacking common a superscript letter differ (P<0.05). 
jStandard error of the interaction means. 
 
Figure 9.  Values for L* for Chops from Acetate or Citrate Injection at 50 min Post-
mortem, Phosphate plus Salt Injection at 24 h, and Non-injected Controls over 7 d of Dis-
play. 
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a-oMeans lacking common a superscript letter differ (P<0.05). 
pStandard error of the interactions means. 
 
Figure 10.  Values for a* for Longissimus Chops from Acetate or Citrate Injection at 50 
min Post-mortem, Phosphate plus Salt Injection at 24 h, and Non-injected Controls over 7 
d of Display. 
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a-kMeans lacking common a superscript letter differ (P<0.05). 
lStandard error of the interaction means. 
 
Figure 11.  Values for b* for Longissimus Chops from Acetate or Citrate Injection at 50 
min Post-mortem, Phosphate plus Salt Injection at 24 h, and Non-injected Controls over 7 
d of Display 
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